ISRCTN23032971CompletedNot Applicable
Morning versus evening dosing of desloratadine in seasonal allergic rhinitis: a randomised controlled study
Schering-Plough AS (Norway)0 sites663 target enrollmentStarted: February 1, 2005Last updated:
Conditions
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Sponsor
- Enrollment
- 663
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Sex
- All
Inclusion Criteria
- •1. Patients 18 years or above with a minimum of two years history of SAR confirmed by either a positive skin prick test or a positive serologic allergen test to the relevant seasonal allergen
- •2. Clinically symptomatic with SAR at baseline/inclusion with a minimum total nasal symptom score (rhinorrhoea, congestion, itching and sneezing) of at least 6 and rhinorrhoea being minimum 2 (moderate)
- •3. Willingness to adhere to dosing and visit schedule
- •4. Females of childbearing potential have to use medically accepted methods of birth control
- •5. Written informed consent
Exclusion Criteria
- •1. Pulmonary disease, perennial rhinitis, sinusitis, rhinitis medicamentosa, pollen desensitisation during the last 6 months
- •2. Respiratory tract infection within the last two weeks
- •3. Structural nasal abnormalities (including polyps)
- •4. Use of oral, nasal, ocular decongestants, corticosteroids in any form (except mild dermatological group I corticosteroids allowed in only small areas), other antihistamines (oral or topical), any investigational drug during the last 30 days
- •5. Pregnant or nursing females
Investigators
Similar Trials
Completed
Not Applicable
Comparison of morning vs evening dosing of the latanoprost/timolol maleate fixed combination (Xalacom) on intraocular pressure control in primary open angle glaucoma. -Pilot Studyprimary open angle glaucomaJPRN-UMIN000011275Department of Ophthalmology, Kanazawa University40
Completed
Phase 2
Comparing the effectiveness of combination therapy and monotherapy on quality of life in patients with persistent allergic rhinitisallergic rhinitis.Vasomotor and allergic rhinitisIRCT20200909048677N1Kashan University of Medical Sciences56
Active, not recruiting
Not Applicable
Combined treatment of cinnarizine and iprazochrome in urticaria factitiaEUCTR2012-004002-10-HUDepartment of Dermatology and Allergology, University of Szeged
Terminated
Not Applicable
Morning to evening ratio in total dose of twice-daily biphasic insulin analog in achieving glucose control in patients with poorly controlled type 2 diabetesEndocrine, nutritional and metabolic diseaseKCT0000568Yonsei University Health System, Severance Hospital100
Completed
Not Applicable
Evening versus morning administration of levothyroxineISRCTN17436693Medical Centre Rijnmond-Zuid (MCRZ) (The Netherlands)100
